human snai1 (Addgene inc)
Structured Review

Human Snai1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 23 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human snai1/product/Addgene inc
Average 93 stars, based on 23 article reviews
Images
1) Product Images from "The Epithelial–Mesenchymal Transcription Factor SNAI1 Represses Transcription of the Tumor Suppressor miRNA let-7 in Cancer"
Article Title: The Epithelial–Mesenchymal Transcription Factor SNAI1 Represses Transcription of the Tumor Suppressor miRNA let-7 in Cancer
Journal: Cancers
doi: 10.3390/cancers13061469
Figure Legend Snippet: Growth factor treatment results in increased SNAI1, increased stemness and decreased let-7 expression. MCF-7, PANC-1 were treated with TGFB1; OVCAR8, OVSAHO were treated with EGF. Levels of control group (cells treated with vehicle control) were normalized to 1. Values for RT-qPCR are shown on a log scale. ( A , B ) RT-qPCR analysis for mRNA expression level of SNAI1 ( A ) and of stemness markers (( B ), LIN28A, NANOG, POU5F1 and HMGA2 ). ( C , D ) The quantification of Western blot analysis for protein expression of SNAI1 ( C ) and HMGA2 ( D ). ( E ) Left panel: The quantification of number of spheroids per 3000 cells (both first passage and second passage) is shown. Right panel: Phase contrast images of spheroids formed from cells (first passage) as indicated are presented. In each panel, the spheroids formed from control group are presented on the left, those from the treatment group are on the right. Scale bar = 100 μm ( F ) RT-qPCR analysis for let-7 miRNA ( let-7a , let-7e , let-7g and let-7i) expression. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Techniques Used: Expressing, Control, Quantitative RT-PCR, Western Blot
Figure Legend Snippet: SNAI1 overexpression results in increased stemness and decreased let-7 expression. Cell lines were transduced with the retroviral expression vector pWZL-Snail or empty vector, pWZL-Empty, in cell lines MCF-7, PANC-1, OVCAR8 and OVSAHO. Levels of control group (cells transduced with pWZL-Empty) were normalized to 1. Values for RT-qPCR are shown on a log scale. ( A , B ) RT-qPCR analysis for mRNA expression of SNAI1 ( A ) and of stemness markers LIN28A , NANOG , POU5F1 and HMGA2 ( B ). ( C , D ) The quantification of Western blot analysis for protein expression of SNAI1 ( C ) and HMGA2 ( D ). ( E ) The quantification of number of spheroids formed per 3000 cells (both first passage and second passage) as indicated. ( F ) RT-qPCR analysis for let-7 miRNA ( let-7a , let-7e , let-7g and let-7i) expression. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001
Techniques Used: Over Expression, Expressing, Transduction, Retroviral, Plasmid Preparation, Control, Quantitative RT-PCR, Western Blot
Figure Legend Snippet: SNAI1 knockdown reverses stemness and restores let-7 expression. Mesoporous silica nanoparticles coated with hyaluronic acid (HA-MSN) were used to deliver siRNA (siSnail and siControl) in MCF-7, PANC-1, OVCAR8, and OVSAHO. Levels of control group (cells treated with siControl) were normalized to 1. Values for RT-qPCR are shown on a log scale. Samples were harvested after 24 h (MCF-7, OVCAR8 and OVSAHO) or 72 h (PANC-1). ( A , B ) RT-qPCR analysis for mRNA expression of SNAI1 ( A ) and of stemness markers LIN28A , NANOG , POU5F1 and HMGA2 ( B ). ( C , D ) The quantification of Western blot analysis for protein expression of SNAI1 ( C ) and HMGA2 ( D ). ( E ) The quantification of number of spheroids formed per 3000 cells (both first passage and second passage) as indicated. ( F ) RT-qPCR analysis for let-7 miRNA ( let-7a , let-7e , let-7g , and let-7i ) expression. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001
Techniques Used: Knockdown, Expressing, Control, Quantitative RT-PCR, Western Blot
Figure Legend Snippet: SNAI1 knockdown reduces stemness in patient-derived cells in vitro. HA-MSN were used to deliver siRNA (siSnail and siControl) in PDX cells in vitro. Levels of control group (cells treated with siControl) were normalized to 1. Values for RT-qPCR are shown on a log scale. ( A , B ) RT-qPCR analysis for mRNA expression of SNAI1 ( A ) and of stemness markers LIN28A , NANOG , POU5F1 and HMGA2 ( B ). ( C , D ) The quantification of Western blot analysis for protein expression of SNAI1 ( C ) and HMGA2 ( D ). ( E ) The quantification of number of spheroids per 3000 cells formed from PDX6 in vitro. ( F ) RT-qPCR analysis for let-7 miRNA ( let-7a , let-7e , let-7g, and let-7i ) expression. * p < 0.05; ** p < 0.01; *** p < 0.001.
Techniques Used: Knockdown, Derivative Assay, In Vitro, Control, Quantitative RT-PCR, Expressing, Western Blot
Figure Legend Snippet: SNAI1 knockdown in vivo reduces stemness gene expression and tumor burden. HA-MSN were used to deliver siRNA (siSnail and siControl) via IV injection to orthotopic PDX in vivo. Tumor samples were harvested and analyzed at necropsy. Levels of control group (cells treated with siControl) were normalized to 1. Values for RT-qPCR are shown on a log scale. ( A , B ) RT-qPCR analysis for mRNA expression of SNAI1 ( A ) and of stemness markers LIN28A , NANOG , POU5F1 and HMGA2 ( B ), in tumors. ( C , D ) The quantification of Western blot analysis for protein expression of SNAI1 ( C ) and stemness markers LIN28A and HMGA2 ( D ), in tumors. ( E ) RT-qPCR analysis for let-7 miRNA ( let-7a , let-7e , let-7g and let-7i ) expression in tumors. ( F ) Left panel: Representative images of xenograft mice. siControl (upper) and siSnail knockdown (lower). Right panel: Quantitation of bioluminescence at primary sites over six weeks. X axis, days; Y axis, total flux in photons/second relative to day 1. * p < 0.05; ** p < 0.01; *** p < 0.001.
Techniques Used: Knockdown, In Vivo, Gene Expression, IV Injection, Control, Quantitative RT-PCR, Expressing, Western Blot, Quantitation Assay
Figure Legend Snippet: SNAI1 represses let-7 promoters. ( A ) Schematic representation of the promoter region of let- 7 i (upper) and reporter constructs used in luciferase assays (lower diagrams). E1, E2, E3: E-boxes (sequence: CANNTG); MU: Mutated E-boxes; TSS: Transcription start site ( B ) For luciferase assays, HEK293T cells were co-transfected with two plasmids: (1) let-7 promoter luciferase (let-7i, let-7a1/d/f1, let-7a3/b, let-7c) , and (2) either SNAI1 (constitutively expressed, gray bars) or empty vector (black bars). Luminescence activity was measured 48 h thereafter. ( C ) HEK293T cells were co-transfected with either let-7i lucB or let-7i mlucB with or without SNAI1. Luminescence was measured 24 h later. * p < 0.05; ** p < 0.01.
Techniques Used: Construct, Luciferase, Sequencing, Transfection, Plasmid Preparation, Activity Assay
